Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Arrived
EquityMultiple
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Premium Newsletters
Smart Value
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
NXTC
Stock Latest News
Ratings
Optimistic Buy Rating for NextCure Driven by Promising Developments in LNCB74 for Endometrial Cancer
16d ago
NXTC
Premium
The Fly
H.C. Wainwright says competitor data builds optimism for NextCure’s LNCB74
16d ago
AZN
PFE
Premium
Company Announcements
Nextcure Faces Delisting Risk Amid Nasdaq Compliance Struggles
25d ago
NXTC
Premium
Company Announcements
NextCure Reports 2024 Financials and Strategic Progress
25d ago
NXTC
Premium
Ratings
NextCure’s Promising Trajectory: Buy Rating Backed by Clinical Progress and Competitive Edge
26d ago
NXTC
Premium
The Fly
NextCure announces first patient dosed in Phase 1 study of LNCB74
3M ago
NXTC
Premium
The Fly
NextCure announces acceptance of IND application for LNCB74
4M ago
NXTC
Premium
Company Announcements
NextCure Advances with New Cancer Drug Application
4M ago
8K
NXTC
Premium
The Fly
NextCure announces preclinical data on NC605
4M ago
NXTC
Premium
Company Announcements
NextCure Reports Improved Financial Performance and Strategic Focus
5M ago
NXTC
Premium
Company Announcements
NextCure to Discuss Innovative Cancer Therapies
5M ago
8K
NXTC
Premium
The Fly
NextCure reports Q3 EPS (41c), consensus (34c)
5M ago
NXTC
Premium
The Fly
NextCure reports data from LNCB74, NC410 studies
5M ago
NXTC
Premium
Pre-Earnings
NXTC Upcoming Earnings Report: What to Expect?
5M ago
NXTC
Premium
The Fly
NextCure announces data from Phase 1b trial evaluating NC410
7M ago
NXTC
Premium
The Fly
NextCure reports Q2 EPS (55c), consensus (38c)
8M ago
NXTC
Premium
The Fly
NextCure presents Phase 1b data on NC410 and pembrolizumab combo at ASCO
10M ago
NXTC
Premium
The Fly
NextCure treatment of osteogenesis imperfecta granted orphan designation
10M ago
NXTC
Premium
The Fly
NextCure reports Q1 EPS (61c), consensus (46c)
11M ago
NXTC
Premium
The Fly
NextCure and LCB present data on B7-H4 antibody drug conjugate at AACR
12M ago
NXTC
Premium
The Fly
NextCure appoints Rakesh Dixit to Scientific Advisory Board
12M ago
NXTC
Premium
Company Announcements
NextCure Inc to Engage with Investors in Informal Talks
1y ago
8K
NXTC
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
